Sight Sciences, Inc.

Sight Sciences, Inc. announced it will report its financial results for the second quarter ended June 30, 2026, after the market closes on Wednesday, August 5, 2026. The company's management will host a conference call to discuss the results at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the event will be available on the Investors page of the company's website.

Sight Sciences, Inc. reported strong financial results for the first quarter ended March 31, 2026, with total revenue increasing 13% year-over-year to $19.7 million, driven by significant growth in its Interventional Dry Eye segment. The company also raised its full-year 2026 revenue guidance to a range of $83.0 million to $89.0 million. Additionally, a U.S. District Court issued a final judgment in the company's patent infringement case against Alcon, awarding Sight Sciences $55.4 million in past monetary damages and an ongoing royalty of 10% on Hydrus Microstent revenue.

Sight Sciences, Inc. received a final judgment from the U.S. District Court for the District of Delaware, upholding a jury's finding that Alcon's Hydrus® Microstent willfully infringed three of Sight Sciences' patents. The court awarded Sight Sciences total monetary damages of $55.4 million, comprising past damages, supplemental damages, and interest. Additionally, the company was granted an ongoing royalty of 10% of Hydrus revenue through the expiration of the last patent. The judgment is subject to appeal by Alcon, and monetary damages will not be received until appeals are exhausted.

Sight Sciences, Inc. announced the publication of its third annual Sustainability Report, detailing its environmental, social, and governance (ESG) activities and performance over the past three years. The report highlights the company's commitment to transparency, operational discipline, and environmental impact reduction, aiming to create long-term value for stakeholders. Key achievements include a significant reduction in emissions and a diverse workforce, reinforcing the company's mission to elevate eyecare standards while maintaining strong ESG practices.

Sight Sciences, Inc. announced it will report its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 6, 2026. Management will host a conference call to discuss these results at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. Investors can access a live and archived webcast of the event on the company's investor relations website.